AG
DRNA

Advisor Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Advisor Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$20K Buy
906
+706
+353% +$14.2K ﹤0.01% 3973
2019
Q3 		$3K Hold
200
– – ﹤0.01% 4908
2019
Q2 		$3K Hold
200
– – ﹤0.01% 4915
2019
Q1 		$3K Hold
200
– – ﹤0.01% 4894
2018
Q4 		$2K Hold
200
– – ﹤0.01% 4875
2018
Q3 		$3K Hold
200
– – ﹤0.01% 4785
2018
Q2 		$2K Sell
200
-300
-60% -$3.77K ﹤0.01% 4724
2018
Q1 		$5K Hold
500
– – ﹤0.01% 4448
2017
Q4 		$5K Buy
+500
New +$3.68K ﹤0.01% 4437

Other funds holding DRNA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Advisor Group's DRNA Position: Q4 2019 in Review

Advisor Group increased its Dicerna Pharmaceuticals, Inc. (DRNA) stake by 353% in Q4 2019, buying an estimated $14.2K and bringing the position to 906 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #3973.

Advisor Group first reported a position in DRNA in Q4 2017 and has held it in 9 quarters since. 169 funds tracked by Wall St. Rank hold DRNA as of Q4 2019.

  • Advisor Group held 906 shares of Dicerna Pharmaceuticals, Inc. worth $20K as of Q4 2019.
  • Advisor Group bought 706 Dicerna Pharmaceuticals, Inc. shares in Q4 2019, an estimated $14.2K.
  • Dicerna Pharmaceuticals, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3973 holding.
  • Advisor Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2017 and has held it in 9 quarters since.
  • 169 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.